Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Hemcheck Sweden

Mindre end 1K følgere
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse13.11.2024, 14.15

Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider

Hemcheck Sweden
Selskabsmeddelelse12.2.2024, 12.50

Bio Vitos Pharma AB: KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer

Hemcheck Sweden
Selskabsmeddelelse20.12.2023, 06.30

Bio Vitos Pharma AB: The European Patent Office EPO grants patent that is important to Bio Vitos Pharma

Hemcheck Sweden

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse20.10.2023, 14.20

Hemcheck completes the transaction with Bio Vitos

Hemcheck Sweden
Selskabsmeddelelse15.5.2023, 13.20

Hemcheck has received a first order from its distributor Astemed

Hemcheck Sweden
Selskabsmeddelelse4.5.2023, 12.00

Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement

Hemcheck Sweden
Selskabsmeddelelse26.4.2023, 14.20

Hemcheck: Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)

Hemcheck Sweden
Selskabsmeddelelse5.4.2023, 20.50

Hemcheck has received a first order from the university hospital Charité in Berlin

Hemcheck Sweden
Selskabsmeddelelse16.3.2023, 12.10

Hemcheck: Additional agreement with Bio Vitos Medical brings forward the time for calling the extraordinary general meeting by one week

Hemcheck Sweden
Selskabsmeddelelse13.3.2023, 16.00

Hemcheck has received a first follow up order from its Finnish distributor

Hemcheck Sweden
Selskabsmeddelelse2.3.2023, 16.00

Hemcheck has received an additional follow up order from its UK distributor

Hemcheck Sweden
Selskabsmeddelelse28.2.2023, 20.15

Hemcheck receives follow up order from research program in the United States

Hemcheck Sweden
Selskabsmeddelelse3.2.2023, 15.30

Hemcheck has received a follow up order from its French distributor

Hemcheck Sweden
Selskabsmeddelelse1.2.2023, 13.30

Hemcheck has received a follow up order from its UK distributor

Hemcheck Sweden
Selskabsmeddelelse24.1.2023, 16.00

Hemcheck has received a first order from a leading hospital in Iceland

Hemcheck Sweden
Selskabsmeddelelse23.1.2023, 10.00

Hemcheck has received a follow up order from its Spanish distributor

Hemcheck Sweden
Selskabsmeddelelse16.1.2023, 21.30

Hemcheck has received another follow up order from its Irish distributor

Hemcheck Sweden
Selskabsmeddelelse3.1.2023, 16.27

Hemcheck extends agreement regarding previously communicated project with Region Skåne

Hemcheck Sweden
Selskabsmeddelelse20.12.2022, 09.00

Hemcheck has received a follow up order from its Irish distributor

Hemcheck Sweden
Selskabsmeddelelse12.12.2022, 14.00

Hemcheck has received an important order from a major OEM

Hemcheck Sweden
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.